Details for New Drug Application (NDA): 006905
✉ Email this page to a colleague
NDA 006905 describes NORISODRINE, which is a drug marketed by Abbvie and Abbott and is included in two NDAs. Additional details are available on the NORISODRINE profile page.
The generic ingredient in NORISODRINE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
The generic ingredient in NORISODRINE is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.
Summary for 006905
| Tradename: | NORISODRINE |
| Applicant: | Abbvie |
| Ingredient: | isoproterenol sulfate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INHALATION | Strength | 25% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INHALATION | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
